Advertisement

Topics

REMS Barriers: US FDA Takes 'Foundational Step' To Improve Generic Access

17:19 EST 8 Nov 2017 | SCRIP

Generic firms might be able to purchase branded drugs for bioequivalence studies from Europe under concepts that FDA is considering...

      

Related Stories

 

Original Article: REMS Barriers: US FDA Takes 'Foundational Step' To Improve Generic Access

NEXT ARTICLE

More From BioPortfolio on "REMS Barriers: US FDA Takes 'Foundational Step' To Improve Generic Access"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...